Connor, Clark & Lunn Investment Management (CC&L)’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.75M	Sell	117,954 -103,490	-47%	-$3.87M	0.01%	698
2025 Q4	$7.71M	Sell	221,444 -148,425	-40%	-$11.7M	0.02%	530
2025 Q3	$30.7M	Buy	369,869 +51,864	+16%	+$3.75M	0.1%	194
2025 Q2	$23.3M	Sell	318,005 -433,213	-58%	-$31.4M	0.08%	216
2025 Q1	$85.8M	Sell	751,218 -45,577	-6%	-$2.77M	0.37%	50
2024 Q4	$40.2M	Sell	796,795 -62,768	-7%	-$3.29M	0.18%	99
2024 Q3	$39.8M	Buy	859,563 +143,507	+20%	+$5.1M	0.19%	85
2024 Q2	$23.3M	Buy	716,056 +173,878	+32%	+$4.76M	0.1%	169
2024 Q1	$13.7M	Buy	542,178 +180,971	+50%	+$4.28M	0.06%	254
2023 Q4	$11.7M	Sell	361,207 -1,229	-0.3%	-$33.7K	0.05%	253
2023 Q3	$9.87M	Sell	362,436 -472	-0.1%	-$13.7K	0.05%	250
2023 Q2	$8.07M	Buy	362,908 +141,896	+64%	+$3.27M	0.04%	300
2023 Q1	$4.79M	Buy	221,012 +82,269	+59%	+$1.8M	0.03%	378
2022 Q4	$2.82M	Buy	138,743 +56,445	+69%	+$1.41M	0.02%	468
2022 Q3	$2.11M	Buy	82,298 +7,634	+10%	+$204K	0.01%	488
2022 Q2	$1.78M	Sell	74,664 -62,886	-46%	-$1.37M	0.01%	495
2022 Q1	$3.1M	Buy	137,550 +89,449	+186%	+$1.9M	0.02%	406
2021 Q4	$952K	Buy	48,101 +36,251	+306%	+$735K	﹤0.01%	686
2021 Q3	$233K	Buy	+11,850	New	+$248K	﹤0.01%	924